US Pharma MarketingUK regulators greenlight Lilly’s Foundayo, intensifying Novo competition
The MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU.
The MHRA is the first European regulator to give Foundayo a regulatory blessing, with the drug still under review by the EU.
Source: Pharmaceutical Technology